Latest Articles

Publication Date
All News Scientific
Sentinel lymph node distribution in endometrial cancer: clinical patterns and implications from a 292-patient cohort - Via Medica Journals

Sentinel lymph node distribution in endometrial cancer: clinical patterns and implications from a 292-patient cohort Via Medica Journals

Published: April 22, 2026, 2:34 p.m.
Read Full Article
CR Double-Crane Pharma Gets Nod to Name Unit as Marketer of Endometriosis Drug - 富途牛牛

CR Double-Crane Pharma Gets Nod to Name Unit as Marketer of Endometriosis Drug 富途牛牛

Published: April 22, 2026, 2:09 p.m.
Read Full Article
Neoadjuvant Chemotherapy Followed by Radical Cytoreductive Surgery in Serous Endometrial Carcinoma With Inguinal Lymph Node Metastasis: A Case Report - Cureus

Neoadjuvant Chemotherapy Followed by Radical Cytoreductive Surgery in Serous Endometrial Carcinoma With Inguinal Lymph Node Metastasis: A Case Report Cureus

Published: April 9, 2026, 9:38 a.m.
Read Full Article
An immunodeficient patient with adenomyosis of the uterus complicated | IJWH - Dove Medical Press

An immunodeficient patient with adenomyosis of the uterus complicated | IJWH Dove Medical Press

Published: March 4, 2026, 5:54 a.m.
Read Full Article
Sensei Biotherapeutics Acquires Faeth Therapeutics, Raises $200M to Advance Multi-Node Cancer Therapy for Endometrial and Breast Cancer - Femtech Insider

Sensei Biotherapeutics Acquires Faeth Therapeutics, Raises $200M to Advance Multi-Node Cancer Therapy for Endometrial and Breast Cancer Femtech Insider

Published: Feb. 18, 2026, 3:28 p.m.
Read Full Article
Sensei Biotherapeutics Acquires Faeth Therapeutics in $200M Deal, Advancing Multi-Node Cancer Therapy for Endometrial and Breast Cancer - Femtech Insider

Sensei Biotherapeutics Acquires Faeth Therapeutics in $200M Deal, Advancing Multi-Node Cancer Therapy for Endometrial and Breast Cancer Femtech Insider

Published: Feb. 18, 2026, 3:28 p.m.
Read Full Article
AstraZeneca Pharma India Secures CDSCO Nod for Expanded Use of Durvalumab in Cancer Treatment - NewsGram

AstraZeneca Pharma India Secures CDSCO Nod for Expanded Use of Durvalumab in Cancer Treatment NewsGram

Published: Feb. 11, 2026, 3:33 a.m.
Read Full Article
AstraZeneca gets regulator’s nod to market cancer drug Imfinzi for additional indication - thehindu.com

AstraZeneca gets regulator’s nod to market cancer drug Imfinzi for additional indication thehindu.com

Published: Feb. 10, 2026, 9:33 a.m.
Read Full Article
AstraZeneca gets regulator’s nod to market cancer drug Imfinzi for additional indication - The Hindu

AstraZeneca gets regulator’s nod to market cancer drug Imfinzi for additional indication The Hindu

Published: Feb. 10, 2026, 9:33 a.m.
Read Full Article
AstraZeneca gets Indian regulator's nod to market cancer drug Imfinzi - Business Standard

AstraZeneca gets Indian regulator's nod to market cancer drug Imfinzi Business Standard

Published: Feb. 10, 2026, 9:10 a.m.
Read Full Article
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!